ha.mwangi
Submits third-party assay reports on material purchased directly. Based in Tampere.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.25%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041842 | Survodutide | GSP | GSP-2603-E2342 | Kestrel | 2026-Q3 | 99.32 | 5.67 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041467 | SS-31 (Elamipretide) | QYB | QYB-2512-H5180 | Nordanalyt | 2026-Q2 | 99.66 | 5.27 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020859 | Semaglutide | SGN | SGN-2502-F1304 | PeptideMeter | 2025-Q3 | 99.25 | 5.18 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019044 | NAD+ | GSP | GSP-2503-B2806 | Nordanalyt | 2025-Q3 | 99.93 | 10.47 | 102.1 | Buyer-sourced | 0 | FAIL |
| AX-2025-020428 | Liraglutide | MKM | MKM-2508-P5150 | Janoshik | 2025-Q3 | 97.85 | 6.90 | 98.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019202 | Survodutide | HYB | HYB-2504-X5304 | PeptideMeter | 2025-Q3 | 99.00 | 4.23 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018682 | MK-677 (Ibutamoren mesylate) | QSC | QSC-2507-F6524 | Nordanalyt | 2025-Q3 | 99.61 | 4.73 | 94.2 | Buyer-sourced | 0 | FAIL |
| AX-2025-021359 | AOD-9604 | BCH | BCH-2504-B8271 | Janoshik | 2025-Q3 | 98.64 | 2.68 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005137 | PT-141 (Bremelanotide) | MKM | MKM-2406-H3933 | PeptideMeter | 2024-Q3 | 98.28 | 5.61 | 96.9 | Laboratory-retained | 1 | FAIL |